Sun.Jul 28, 2024

article thumbnail

Opinion: Survey: Neurologists split on prescribing new Alzheimer’s treatments

STAT

As more than 7,500 clinicians and researchers converge in Philadelphia for the Alzheimer’s Association International Conference , a sharp division is emerging over new treatments for the disease that brings them together each year. This divide is over when to prescribe one of the newer drugs to treat Alzheimer’s disease. Lecanemab (Leqembi) was approved by the U.S.

342
342
article thumbnail

LEO closes on first approval for chronic hand eczema drug

pharmaphorum

The CHMP has backed LEO Pharma's delgocitinib for chronic hand eczema, considered to be one of its top pipeline prospects

111
111
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

US FDA flags dosing risks from compounded versions of Novo’s weight-loss drug

Express Pharma

The U.S. Food and Drug Administration recently warned patients and doctors about dosing errors associated with compounded versions of Novo Nordisk’s weight-loss and diabetes drugs. The health regulator said it had received reports of adverse events, some requiring hospitalisation, that may be related to overdoses due to patients incorrectly self-administering the compounded drug and healthcare providers miscalculating doses.

article thumbnail

The Role of Patient Advocacy Groups in Generic Drug Development

Drug Patent Watch

Patient advocacy groups have become increasingly influential in the pharmaceutical industry, particularly in the development of generic drugs.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Phase III post-marketing commitment study data paves way for usage of Paratek’s Nuzyra in other indications: GlobalData

Express Pharma

Paratek Pharmaceuticals has announced positive topline efficacy and safety data from a global, Phase III post-marketing commitment study of its novel antibiotic, a next-generation tetracycline, Nuzyra (omadacycline). In a study of 670 adults with moderate to severe community-acquired bacterial pneumonia (CABP), Nuzyra was found to be generally safe and well-tolerated.

article thumbnail

The Impact of International Trade Agreements on Drug Patents: A Systematic Review

Drug Patent Watch

The Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) sets minimum standards for intellectual property protection globally, including patents […] Source

75

More Trending

article thumbnail

Exploring best-practice manufacturing strategies for highly potent oral solid dosage forms

PharmaTech

As the number of highly potent oral solid dose (HPOSD) drugs in development and on the market increases, so are regulator’s expectations regarding their safe manufacture. In this white paper Pfizer CentreOne examines what developers and their manufacturing partners need to know about its unique regulatory challenges and how to navigate HPOSD’s complex manufacturing environment successfully.

Dosage 52
article thumbnail

Episode 943: Risk Factors Associated With the Development of Venous Thromboembolism in ICU Patients

Pharmacy Joe

In this episode, I’ll discuss the risk factors associated with the development of venous thromboembolism in ICU patients. Episode 943: Risk Factors Associated With the Development of Venous Thromboembolism in ICU Patients Subscribe on iTunes , Android , or Stitcher An review and systematic analysis published in Critical Care Medicine evaluated 39 observational cohort studies involving over 700,000 patients to identify what risk factors were associated with the development of VTE in critically il

article thumbnail

New tentative approval for Alembic drug dabigatran etexilate mesylate

Drug Patent Watch

Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd Iii, and Boehringer Ingelheim and, and is included in five NDAs.

52
article thumbnail

Aripiprazole Versus Risperidone Comparison

Med Ed 101

We will compare aripiprazole versus risperidone and why a clinician might recommend one versus another. These two agents are two of the most commonly used antipsychotics in practice. Antipsychotics are most often used for psychiatric disorders like schizophrenia and bipolar disorder. They can also be considered for other behavioral issues and in the case of […] The post Aripiprazole Versus Risperidone Comparison appeared first on Med Ed 101.

52
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Drug Patent Expirations for the Week of July 28, 2024

Drug Patent Watch

ALOXI (palonosetron hydrochloride) Helsinn hlthcare Patent: 7,947,725 Expiration: Jul 30, 2024 See More … For more information on how DrugPatentWatch […] Source

52
article thumbnail

Pharmaceutical Technology Excellence Awards 2024: SecureCHEK AI

Pharmaceutical Technology

SecureCHEK AI is a Category Award Winner in four areas in the 2024 Pharmaceutical Technology Excellence Awards

59
article thumbnail

Which pharmaceutical companies have the most powder dosed drugs?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most powder dosed drugs. For a different perspective, see the most popular dosage types.